article Open AccessTop 1% cited

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline

The Journal of Clinical Endocrinology & Metabolism · 2010 · Vol. 95(9) · pp. 4133–4160

Phyllis Speiser✉(Hofstra University)Ricardo Azziz(Cedars-Sinai Medical Center)Laurence S. Baskin(University of California, San Francisco)Lucia Ghizzoni(University of Turin)Terry W. Hensle(Columbia University)Deborah P. Merke(National Institutes of Health)Heino F. L. Meyer‐Bahlburg(Columbia University)Walter L. Miller(University of California, San Francisco)Víctor M. Montori(Mayo Clinic)Sharon E. Oberfield(Columbia University)Martin Ritzén(Karolinska Institutet)Perrin C. White(Pediatrics and Genetics)

View via DOI Full-text PDF

Abstract

The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.

Sexual Differentiation and Disorders Metabolism and Genetic Disorders Growth Hormone and Insulin-like Growth FactorsCongenital adrenal hyperplasiaMedicineGuidelineEndocrine systemPediatricsAdrenal crisisIntensive care medicineInternal medicineAdrenal insufficiencyHormone

MeSH terms

Adrenal Hyperplasia, CongenitalAlgorithmsFemaleHumansInfant, NewbornModels, BiologicalPregnancySteroid 21-HydroxylaseComorbidityNeonatal ScreeningPractice Guidelines as TopicEvidence-Based Practice

Citations

1,467

FWCI

30.70

field-weighted impact

References

340

Percentile

100%

vs. same field & year

Citations per year

Cited by